The Role of DPP-IV Inhibitors in the Management of Type 2 Diabetes (Endocrinology)

Pay with

About The Role Of DPP-IV Inhibitors In The Management Of

Product Description Type 2 Diabetes is a progressive disease that occurs as a result of metabolic dysfunction. Gastrointestinal hormones produced as a result of nutrient ingestion contribute to the secretion of insulin. They not only enhance the secretion of insulin, but also play a vital role in the neogenesis and proliferation of Pancreatic beta cells and the inhibition of glucagons.This presentation is a visual account of Type 2 Diabetes and the beneficial use of DPP-IV inhibitors in taking control of the body’s natural metabolism.Features:No installations or passwords requiredEach CD-ROM is packed for MS-WINDOWS operating system; best viewed in resolution 1024 X 768.The CD-ROM provides option to choose  * Play Full Presentation: full topic runs as a single video  * Interactive Mode: the option of viewing section-wise About the Author ANTHONY H. BARNETT, MD, FRCP, is a Professor of Medicine in the University of Birmingham and Consultant Physician in Birmingham Heartlands Hospital. He leads one of the biggest Diabetes Units in the UK and has published nearly 300 original research papers and contributed to many books on diabetes and its management. He is editor of the journals Modern Diabetes Management, Modern Hypertension Management and Obesity in Practice.